| 000 | 01680 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250512225710.0 | ||
| 264 | 0 | _c19840127 | |
| 008 | 198401s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/BF00254195 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChild, J A | |
| 245 | 0 | 0 |
_aA pilot study of cyclical chemotherapy with high-dose methotrexate and CHOP (MTX-CHOP) in poor-prognosis non-Hodgkin's lymphoma (NHL). _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1983 |
||
| 300 |
_a153-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aCyclophosphamide _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphoma _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aBarnard, D L | |
| 700 | 1 | _aCartwright, S C | |
| 700 | 1 | _aLauder, I | |
| 700 | 1 | _aSimmons, A V | |
| 700 | 1 | _aStone, J | |
| 700 | 1 | _aThorogood, J | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 11 _gno. 3 _gp. 153-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF00254195 _zAvailable from publisher's website |
| 999 |
_c6688767 _d6688767 |
||